期刊
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
卷 105, 期 13, 页码 5248-5253出版社
NATL ACAD SCIENCES
DOI: 10.1073/pnas.0704242105
关键词
beta-catenin; cyclin D1; GSK3 beta
资金
- CIHR [12043] Funding Source: Medline
- NCI NIH HHS [CA64602, CA82716, P01 CA064602, R01 CA082716, P30 CA016672] Funding Source: Medline
In primary mammalian cells, expression of oncogenes such as activated Ras induces premature senescence rather than transformation. We show that homozygous deletion of glycogen synthase kinase (GSK) 3 beta (GSK3 beta(-/-)) bypasses senescence induced by mutant Ras(V12) allowing primary mouse embryo fibroblasts (MEFs) as well as immortalized MEFs to exhibit a transformed phenotype in vitro and in vivo. Both catalytic activity and Axin-binding of GSK3 beta are required to optimally suppress Ras transformation. The expression of Ras(V12) in GSK3 beta(-/-), but not in GSK3 beta(+/+) MEFs results in translocation of beta-catenin to the nucleus with concomitant up-regulation of cyclin D1. siRNA-mediated knockdown of beta-catenin decreases both cyclin D1 expression and anchorage-independent growth of transformed cells indicating a causal role for beta-catenin. Thus Ras(V12) and the lack of GSK3 beta act in concert to activate the beta-catenin pathway, which may underlie the bypass of senescence and tumorigenic transformation by Ras.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据